9-(piperazinylalkyl) carbazoles as Bax-modulators


Ontology type: sgo:Patent     


Patent Info

DATE

N/A

AUTHORS

Serge Halazy , Dennis Church , Bruno Antonsson , Agnes Bombrun , Patrick Gerber , Jean-Claude Martinou

ABSTRACT

Piperazine compounds for use as pharmaceutically active compounds and in pharmaceutical formulations that are useful for the treatment of disorders associated with apoptosis, including neurodegenerative disorders, diseases associated with polyglutamine tracts, epilepsy, ischemia, infertility, cardiovascular disorders, renal hypoxia, hepatitis and AIDS, where the piperazine compounds are represented by formula (I) and the terms R0, R1, R2, R3, k, l, m, n, and X are defined herein: More... »

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2464", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "Serge Halazy", 
        "type": "Person"
      }, 
      {
        "name": "Dennis Church", 
        "type": "Person"
      }, 
      {
        "name": "Bruno Antonsson", 
        "type": "Person"
      }, 
      {
        "name": "Agnes Bombrun", 
        "type": "Person"
      }, 
      {
        "name": "Patrick Gerber", 
        "type": "Person"
      }, 
      {
        "name": "Jean-Claude Martinou", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s0040-4020(01)90362-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001047738"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/42867", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013329324", 
          "https://doi.org/10.1038/42867"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/5985", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014520362", 
          "https://doi.org/10.1038/5985"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1083/jcb.144.5.891", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017472708"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0697-614", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018021633", 
          "https://doi.org/10.1038/nm0697-614"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0223-5234(99)80064-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030856567"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0040-4039(99)00074-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037393981"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0040-4039(96)00318-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045626696"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0962-8924(98)01321-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050495825"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0040-4020(95)00232-w", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052045905"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0896-6273(00)80173-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052781784"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm50004a003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1055954351"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "description": "

Piperazine compounds for use as pharmaceutically active compounds and in pharmaceutical formulations that are useful for the treatment of disorders associated with apoptosis, including neurodegenerative disorders, diseases associated with polyglutamine tracts, epilepsy, ischemia, infertility, cardiovascular disorders, renal hypoxia, hepatitis and AIDS, where the piperazine compounds are represented by formula (I) and the terms R0, R1, R2, R3, k, l, m, n, and X are defined herein:

\"embedded

", "id": "sg:patent.US-8410110-B2", "keywords": [ "modulators", "piperazine", "active compound", "pharmaceutical formulation", "disorder", "apoptosis", "neurodegenerative disease", "disease", "polyglutamine tract", "epilepsy", "ischemia", "infertility", "cardiovascular disorder", "hepatitis", "Acquired Immunodeficiency Syndrome", "formula" ], "name": "9-(piperazinylalkyl) carbazoles as Bax-modulators", "recipient": [ { "id": "https://www.grid.ac/institutes/grid.418389.f", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/US-8410110-B2" ], "sdDataset": "patents", "sdDatePublished": "2019-03-07T15:34", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com.uberresearch.data.dev.patents-pipeline/full_run_10/sn-export/5eb3e5a348d7f117b22cc85fb0b02730/0000100128-0000348334/json_export_962f20a5.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.US-8410110-B2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.US-8410110-B2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.US-8410110-B2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.US-8410110-B2'


 

This table displays all metadata directly associated to this object as RDF triples.

96 TRIPLES      14 PREDICATES      41 URIs      23 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.US-8410110-B2 schema:about anzsrc-for:2464
2 schema:author Nc22a6250b956497b82f0c752f614e967
3 schema:citation sg:pub.10.1038/42867
4 sg:pub.10.1038/5985
5 sg:pub.10.1038/nm0697-614
6 https://doi.org/10.1016/0040-4020(95)00232-w
7 https://doi.org/10.1016/0040-4039(96)00318-8
8 https://doi.org/10.1016/s0040-4020(01)90362-x
9 https://doi.org/10.1016/s0040-4039(99)00074-x
10 https://doi.org/10.1016/s0223-5234(99)80064-6
11 https://doi.org/10.1016/s0896-6273(00)80173-7
12 https://doi.org/10.1016/s0962-8924(98)01321-x
13 https://doi.org/10.1021/jm50004a003
14 https://doi.org/10.1083/jcb.144.5.891
15 schema:description <p num="p-0001">Piperazine compounds for use as pharmaceutically active compounds and in pharmaceutical formulations that are useful for the treatment of disorders associated with apoptosis, including neurodegenerative disorders, diseases associated with polyglutamine tracts, epilepsy, ischemia, infertility, cardiovascular disorders, renal hypoxia, hepatitis and AIDS, where the piperazine compounds are represented by formula (I) and the terms R<sup>0</sup>, R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, k, l, m, n, and X are defined herein:</p><p num="p-0002"><chemistry id="CHEM-US-00001" num="00001"><img id="EMI-C00001" he="45.13mm" wi="62.91mm" file="US08410110-20130402-C00001.TIF" alt="embedded image" img-content="chem" img-format="tif" orientation="portrait" inline="no"/><attachments><attachment idref="CHEM-US-00001" attachment-type="cdx" file="US08410110-20130402-C00001.CDX"/><attachment idref="CHEM-US-00001" attachment-type="mol" file="US08410110-20130402-C00001.MOL"/></attachments></chemistry></p>
16 schema:keywords Acquired Immunodeficiency Syndrome
17 active compound
18 apoptosis
19 cardiovascular disorder
20 disease
21 disorder
22 epilepsy
23 formula
24 hepatitis
25 infertility
26 ischemia
27 modulators
28 neurodegenerative disease
29 pharmaceutical formulation
30 piperazine
31 polyglutamine tract
32 schema:name 9-(piperazinylalkyl) carbazoles as Bax-modulators
33 schema:recipient https://www.grid.ac/institutes/grid.418389.f
34 schema:sameAs https://app.dimensions.ai/details/patent/US-8410110-B2
35 schema:sdDatePublished 2019-03-07T15:34
36 schema:sdLicense https://scigraph.springernature.com/explorer/license/
37 schema:sdPublisher Ne34f66d5212b453a895d924d3952cce9
38 sgo:license sg:explorer/license/
39 sgo:sdDataset patents
40 rdf:type sgo:Patent
41 N3d7c59e9d2e74a66a155fba7187ce0ef rdf:first N416951d1c54f4c349c57ff4311b4c279
42 rdf:rest Nb37850715beb4b30855bcc11242da6d3
43 N416951d1c54f4c349c57ff4311b4c279 schema:name Patrick Gerber
44 rdf:type schema:Person
45 N57876a7fe59c4029b8bc91e11d571493 rdf:first N5e7d59b36d57432796f06ab11b24ac24
46 rdf:rest N7e3f3d4026194f10ab7a4bafc12f6c0d
47 N5e7d59b36d57432796f06ab11b24ac24 schema:name Bruno Antonsson
48 rdf:type schema:Person
49 N68273b591fa54f15ba07336e784cd5ea schema:name Agnes Bombrun
50 rdf:type schema:Person
51 N7e3f3d4026194f10ab7a4bafc12f6c0d rdf:first N68273b591fa54f15ba07336e784cd5ea
52 rdf:rest N3d7c59e9d2e74a66a155fba7187ce0ef
53 Nab7b4422d72f44e6afa84cbff7b0fea9 schema:name Jean-Claude Martinou
54 rdf:type schema:Person
55 Nae318471e60240d28a4a214f62a19f92 schema:name Serge Halazy
56 rdf:type schema:Person
57 Nb37850715beb4b30855bcc11242da6d3 rdf:first Nab7b4422d72f44e6afa84cbff7b0fea9
58 rdf:rest rdf:nil
59 Nbf57004c107f4f47b4741c49997f5743 schema:name Dennis Church
60 rdf:type schema:Person
61 Nc22a6250b956497b82f0c752f614e967 rdf:first Nae318471e60240d28a4a214f62a19f92
62 rdf:rest Ncf6110b3ff7841f6af8f53ac39a1d242
63 Ncf6110b3ff7841f6af8f53ac39a1d242 rdf:first Nbf57004c107f4f47b4741c49997f5743
64 rdf:rest N57876a7fe59c4029b8bc91e11d571493
65 Ne34f66d5212b453a895d924d3952cce9 schema:name Springer Nature - SN SciGraph project
66 rdf:type schema:Organization
67 anzsrc-for:2464 schema:inDefinedTermSet anzsrc-for:
68 rdf:type schema:DefinedTerm
69 sg:pub.10.1038/42867 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013329324
70 https://doi.org/10.1038/42867
71 rdf:type schema:CreativeWork
72 sg:pub.10.1038/5985 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014520362
73 https://doi.org/10.1038/5985
74 rdf:type schema:CreativeWork
75 sg:pub.10.1038/nm0697-614 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018021633
76 https://doi.org/10.1038/nm0697-614
77 rdf:type schema:CreativeWork
78 https://doi.org/10.1016/0040-4020(95)00232-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1052045905
79 rdf:type schema:CreativeWork
80 https://doi.org/10.1016/0040-4039(96)00318-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045626696
81 rdf:type schema:CreativeWork
82 https://doi.org/10.1016/s0040-4020(01)90362-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1001047738
83 rdf:type schema:CreativeWork
84 https://doi.org/10.1016/s0040-4039(99)00074-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1037393981
85 rdf:type schema:CreativeWork
86 https://doi.org/10.1016/s0223-5234(99)80064-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030856567
87 rdf:type schema:CreativeWork
88 https://doi.org/10.1016/s0896-6273(00)80173-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052781784
89 rdf:type schema:CreativeWork
90 https://doi.org/10.1016/s0962-8924(98)01321-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1050495825
91 rdf:type schema:CreativeWork
92 https://doi.org/10.1021/jm50004a003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055954351
93 rdf:type schema:CreativeWork
94 https://doi.org/10.1083/jcb.144.5.891 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017472708
95 rdf:type schema:CreativeWork
96 https://www.grid.ac/institutes/grid.418389.f schema:Organization
 




Preview window. Press ESC to close (or click here)


...